Galychpharm PJSC (UKEX:GFARM) Research & Development: ₴ Mil (TTM As of . 20)


UKEX:GFARM Galychpharm PJSC UKEX:GFARM
14 GF Score
Price ₴100.00
! 1 Warning Sign
View Full Analysis

What is Galychpharm PJSC Research & Development?

Galychpharm PJSC UKEX:GFARM 14 Research & Development is ₴ Mil as of . 20. GuruFocus rates UKEX:GFARM with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Galychpharm PJSC's Research & Development for the six months ended in . 20 was ₴0.00 Mil. Galychpharm PJSC does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Galychpharm PJSC  (UKEX:GFARM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Galychpharm PJSC Research & Development Related Terms

Galychpharm PJSC Research & Development Historical Data

* Premium members only.

The historical data trend for Galychpharm PJSC's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galychpharm PJSC Research & Development Chart

Galychpharm PJSC Annual Data
Trend
Research & Development

Galychpharm PJSC Semi-Annual Data
Research & Development
UKEX:GFARM
14GF Score
Galychpharm PJSC UKEX:GFARM
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galychpharm PJSC Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₴ Mil mean?
Galychpharm PJSC (UKEX:GFARM) has a Research & Development of ₴ Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Galychpharm PJSC and its competitors.
Is Galychpharm PJSC's Research & Development too high?
Galychpharm PJSC's current Research & Development is ₴ Mil. Overall, Galychpharm PJSC has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Galychpharm PJSC's Research & Development compare to HSTC and STLT?
Galychpharm PJSC's Research & Development of ₴ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Galychpharm PJSC and its competitors. Galychpharm PJSC's current Research & Development is ₴ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galychpharm PJSC stock overvalued right now?
Galychpharm PJSC (UKEX:GFARM) has a current Research & Development of ₴ Mil. The current Research & Development is ₴ Mil. Galychpharm PJSC's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Galychpharm PJSC (UKEX:GFARM), the current Research & Development is ₴ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galychpharm PJSC Business Description

Address 6/8 Opryshkivska Street, Lviv, UKR, 79024
Galychpharm PJSC is engaged in the production and sale of drugs and other medicines. It offers phytochemical substances, crude drugs, injection ampoules, tablets, solutions, extracts, and syrups.
14GF Score

Get the complete analysis for UKEX:GFARM

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₴100.00
Price